A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia

A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia

BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune condition characterized by persistent, chronic inflammation that damages organ tissue. One of the symptoms that is often found in SLE is cognitive dysfunction. Hydroxychloroquine is recommended for the treatment of all levels of SLE. Th...

Полное описание

Библиографические подробности
Главные авторы:	Bantar Suntoko, Suharyo Hadisaputro, Handono Kalim, Suyanto Hadi, Ika Vemilia Warlisti
Формат:	Статья
Язык:	English
Опубликовано:	Secretariat of The Indonesian Biomedical Journal 2023-08-01
Серии:	Indonesian Biomedical Journal
Online-ссылка:	https://inabj.org/index.php/ibj/article/view/2504

Схожие документы

Relationship Between Disease Activity, Levels of IFN-a, IL-4, IL-6, and Anti-NMDA to Cognitive Dysfunction (MoCA-INA Score) in Systemic Lupus Erythematosus (SLE) Patients with Cognitive Dysfunction
по: Bantar Suntoko, и др.
Опубликовано: (2023-07-01)

Diagnosis and Management of Cognitive Dysfunction In Systemic Lupus Erythematosus Patients
по: Perdana Aditya Rahman, и др.
Опубликовано: (2022-05-01)

Hyperuricemia and Pro Inflammatory Cytokine (IL-1Î², IL-6, and TNF-Î±)
по: Suyanto Hadi, и др.
Опубликовано: (2018-02-01)

Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus
по: Liu Peng-Cheng, и др.
Опубликовано: (2024-05-01)

Periodontal Tissue Condition on Systemic Lupus Erythematosus Patients: A Clinical Study
по: Nanda Rachmad Putra Gofur, и др.
Опубликовано: (2022-03-01)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
по: Kisha D Piggott, и др.
Опубликовано: (2018-01-01)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
по: Alina Dima, и др.
Опубликовано: (2022-02-01)

Periodontal Comparison on Systemic Lupus Erythematosus Patients and Healthy Subjects: A Cross-Sectional Study
по: Nanda Rachmad Putra Gofur, и др.
Опубликовано: (2021-11-01)

Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus
по: Nanda R.P. Gofur, MS, и др.
Опубликовано: (2019-12-01)

Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus
по: Handono Kalim, и др.
Опубликовано: (2021-10-01)

New onset bullous lupus erythematosus in a systemic lupus erythematosus patient after initiation of hydroxychloroquin
по: Chanchal Gera, и др.
Опубликовано: (2014-01-01)

Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
по: Guillermo Ruiz-Irastorza, и др.
Опубликовано: (2025-02-01)

Hydroxychloroquine in systemic lupus erythematosus and psychosis. A case report
по: M. Martínez Grimal, и др.
Опубликовано: (2024-04-01)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
по: Z. Aouhab, и др.
Опубликовано: (2019-11-01)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
по: David P. Piñero, и др.
Опубликовано: (2017-04-01)

Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus
по: Michele Iudici, и др.
Опубликовано: (2022-03-01)

Oral Hygiene and Dental Caries Status on Systemic Lupus Erythematosus Patients: A Cross-Sectional Study
по: Nanda Rachmad Putra Gofur, и др.
Опубликовано: (2022-03-01)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
по: Alberto Floris, и др.
Опубликовано: (2018-01-01)

Hydroxychloroquine lowers the risk for Diabetes Mellitus in patients with Systemic Lupus Erythematosus
по: Dennis Levinson, и др.
Опубликовано: (2022-10-01)

The phenotype of CD3–CD56bright and CD3–CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
по: Dwi Soelistyoningsih, и др.
Опубликовано: (2022-08-01)

Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis
по: Dwi Soelistyoningsih, и др.
Опубликовано: (2024-09-01)

S15.1 Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
по: S Fasano, и др.
Опубликовано: (2022-10-01)

The Correlation between Serum Concentration of Vitamin D with Vitamin D Receptor Expression and Disease Activity in Indonesian Patients with Systemic Lupus Erythematosus: Preliminary Study
по: Kusworini Handono, и др.
Опубликовано: (2014-05-01)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
по: Ronald F van Vollenhoven, и др.
Опубликовано: (2021-04-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
по: Tomoo Kise, и др.
Опубликовано: (2023-01-01)

An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
по: Atsushi Manabe, и др.
Опубликовано: (2024-04-01)

Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus
по: Peng-Cheng Liu, и др.
Опубликовано: (2024-04-01)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
по: Noël Zahr, и др.
Опубликовано: (2021-03-01)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
по: Bajwa A, и др.
Опубликовано: (2015-05-01)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
по: Wen-Ming Wang, и др.
Опубликовано: (2018-01-01)

Extensive discoid lupus erythematosus in a HIV patient responding to hydroxychloroquine monotherapy
по: Pradeep Vittal Bhagwat, и др.
Опубликовано: (2012-01-01)

Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
по: Mohammed Salah Eldin Abdelbaky, и др.
Опубликовано: (2021-06-01)

CS-31 Safety of hydroxychloroquine withdrawal in older adults with systemic lupus erythematosus
по: Anca Askanase, и др.
Опубликовано: (2018-08-01)

Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment
по: Andrew R. Berneshawi, и др.
Опубликовано: (2024-07-01)

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
по: Peter Izmirly, и др.
Опубликовано: (2021-04-01)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
по: John P. O’Laughlin, и др.
Опубликовано: (2016-01-01)

O9 Early pregnancy exposure to hydroxychloroquine and preterm delivery in systemic lupus erythematosus
по: Elisabet Svenungsson, и др.
Опубликовано: (2024-03-01)

Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus
по: Jae-Eun Lee, и др.
Опубликовано: (2023-05-01)

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus
по: Alexander KC Leung, и др.
Опубликовано: (2020-07-01)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
по: Ruth Fernandez-Ruiz, и др.
Опубликовано: (2020-08-01)